Thrush is one of the most common infections in the world. It's caused by the fungi Candida – specifically, the yeast Candida ...

Scientists warn that Candida, the fungus causing common thrush infections, is rapidly developing resistance to antifungal drugs, complicating treatment options.

In a recent Science Advances study, scientists have developed a novel nanozyme-probiotic combination therapy for Candida vaginitis, which shows potency in killing the causative pathogen, restoring ...

Invasive Candida infections remain an important cause of morbidity and mortality, especially in hospitalized and immunocompromised or critically ill patients. A limited number of antifungal agents ...

Thrush is one of the most common infections in the world. It’s caused by the fungi Candida – specifically, the yeast Candida ...

For over a decade, countless patients with extensive, chronic gastrointestinal complaints have found their way to my clinical nutrition practice believing that “systemic candida” — or, a pervasive ...

Credit: Melinta Therapeutics. Rezzayo is supplied as a solid (cake or powder) in a single-dose vial containing 200mg of rezafungin. Rezzayo ™ (rezafungin for injection) is now available for the ...

The FDA’s advisory committee on antimicrobial drugs on Jan. 25 recommended rezafungin be approved to treat candidemia and invasive candidiasis in adults with limited or no alternative treatment option ...

Background: Invasive candidiasis is increasingly prevalent in premature infants and seriously ill children, and pediatric data on available antifungal therapies are lacking. Methods: We conducted a ...